Biotechnology

Aeterna Zentaris Inc. (NASDAQ: AEZS) today announced completion of its Phase 3 study with AEZS-130 as the first oral diagnostic test for Adult Growth Hormone Deficiency. The Company is currently proceeding with detailed analyses of the data and preparing for a pre-New Drug Application meeting...

Amgen (NASDAQ: AMGN) unveils its next round of earnings this Friday, July 29, 2011. Here's Benzinga's advanced look at Amgen's second quarter earnings report. Earnings and Revenue: Wall Street expects an EPS of $1.30 per share and revenues of $3.78 billion. Amgen's latest numbers will no...

Here are today's Put/Call Ratio leaders… 1. Incyte Corp. (NASDAQ: INCY) 3,542 puts, 152 calls 2. EOG Resources (NYSE: EOG) 5,943 puts, 265 calls 3. Barclays Bank (NYSE: BCS) 12,613 puts, 709 calls 4. Boyd Gaming (NYSE: BYD) 9,744 puts, 618 calls 5. Waste Management (NYSE: WM) 4,629 puts, 302 calls...

Chelsea Therapeutics International, Ltd. (Nasdaq: CHTP) announced positive top-line results of an investigator-led Phase II clinical study of droxidopa in combination with carbidopa in adults with attention deficit hyperactivity disorder. The single-center, 12-week study enrolled 20 patients...

Bank of America Merrill Lynch is out with its report today on Idenix Pharmaceuticals (NASDAQ: IDIX), increasing its PO from $6 to $9. In a note to clients, Bank of America Merrill Lynch writes, "We are increasing our PO from $6 to $9 for IDIX ahead of an important binary event in 4Q (est. Nov),...

Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced several positive developments regarding its anticipated European regulatory filing of NUEDEXTA® (dextromethorphan hydrobromide and quinidine sulfate) capsules for the treatment of pseudobulbar affect. On July 22, 2011, company officials...

Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that it has reached agreement with the U.S. Food and Drug Administration on the Special Protocol Assessment for the design of the Phase 3 REVIVE-CLI clinical trial of ixmyelocel-T, the company's expanded multicellular therapy, in patients...

Dyax Corp. (NASDAQ: DYAX) and Kadmon Corporation, LLC announced today that Dyax has granted Kadmon a non-exclusive license to Dyax's proprietary “gold-standard” antibody phage display libraries for the discovery and development of therapeutic antibodies. Dyax's human antibody phage libraries...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced interim results from ZENITH, an ongoing Phase 2 study designed to assess the safety, tolerability and efficacy of multiple 12- and 24-week response-guided treatment regimens with VX-222 (400 mg or 100 mg), its lead polymerase...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced interim results from ZENITH, an ongoing Phase 2 study designed to assess the safety, tolerability and efficacy of multiple 12- and 24-week response-guided treatment regimens with VX-222 (400 mg or 100 mg), its lead polymerase...

Bank of America has raised the price objective on Idenix Pharmaceuticals (NASDAQ: IDIX) from $6 to $9 and maintains its Buy rating.

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) announced today that the European Medicines Agency accepted for evaluation Vanda's Marketing Authorization Application for oral iloperidone tablets. Iloperidone is an atypical antipsychotic for the treatment of schizophrenia in adults. "The submission in...

Lockheed Martin Corporation (NYSE: LMT) is projected to report its Q2 EPS at $1.93 on revenue of $11.42 billion. Ford Motor Company (NYSE: F) is estimated to report its Q2 earnings at $0.60 per share on revenue of $31.59 billion. Eastman Kodak Company (NYSE: EK) is expected to report a Q2 loss...

Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels and entry/exit points become more defined. The following stocks hit new 52-week highs in Monday's trading session (listed from highest total volume to lowest):...

Direxion Daily Semiconductor Bull 3X Shares (NYSE: SOXL) fell 3.82% on Monday as Teradyne, Inc. (NYSE: TER) lost 2.52%, and Broadcom Corporation (NASDAQ: BRCM) dropped 1.58%. In the after hours, BRCM spiked 7.62% after posting better than expected earnings. ProShares UltraPro Russell2000 ETF (NYSE...